These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37930730)

  • 1. Urinary peptide analysis to predict the response to blood pressure medication.
    Jaimes Campos MA; Mavrogeorgis E; Latosinska A; Eder S; Buchwinkler L; Mischak H; Siwy J; Rossing P; Mayer G; Jankowski J
    Nephrol Dial Transplant; 2024 Apr; 39(5):873-883. PubMed ID: 37930730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detrimental effect of renin-angiotensin blockade on progression of chronic kidney disease at later stages: A matter of dosage adjustment?
    Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2020; 40(1):38-45. PubMed ID: 31196659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Renin-angiotensin System Blockade Improved Short-term and Longterm Renal Outcomes in Systemic Lupus Erythematosus Patients with Antiphospholipid-associated Nephropathy.
    Yue C; Li G; Wen Y; Li X; Gao R
    J Rheumatol; 2018 May; 45(5):655-662. PubMed ID: 29449503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppression.
    Gonzalez-Calero L; Martin-Lorenzo M; de la Cuesta F; Maroto AS; Baldan-Martin M; Ruiz-Hurtado G; Pulido-Olmo H; Segura J; Barderas MG; Ruilope LM; Vivanco F; Alvarez-Llamas G
    Cardiovasc Diabetol; 2016 Jan; 15():8. PubMed ID: 26772976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stopping renin-angiotensin system inhibitors in chronic kidney disease: predictors of response.
    Gonçalves AR; Khwaja A; Ahmed AK; El Kossi M; El Nahas M
    Nephron Clin Pract; 2011; 119(4):c348-54. PubMed ID: 22135795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease.
    Wysocki J; Goodling A; Burgaya M; Whitlock K; Ruzinski J; Batlle D; Afkarian M
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F487-F494. PubMed ID: 28468961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the natural history of diabetic kidney disease (DKD).
    Altemtam N; Russell J; El Nahas M
    Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern and predictors of urine protein excretion among patients with type 2 diabetes attending a single tertiary hospital in Lagos, Nigeria.
    Bello BT; Amira CO
    Saudi J Kidney Dis Transpl; 2017; 28(6):1381-1388. PubMed ID: 29265051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.
    Fernández-Juárez G; Luño J; Barrio V; de Vinuesa SG; Praga M; Goicoechea M; Lahera V; Casas L; Oliva J;
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1870-6. PubMed ID: 24135218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Dual Blockade of the Renin-Angiotensin-Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis.
    Feng Y; Huang R; Kavanagh J; Li L; Zeng X; Li Y; Fu P
    Am J Cardiovasc Drugs; 2019 Jun; 19(3):259-286. PubMed ID: 30737754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy analysis of the renoprotective effects of aliskiren in hypertensive patients with chronic kidney disease.
    Abe M; Suzuki H; Okada K; Maruyama N; Inoshita A; Baba S; Takashima H; Soma M
    Heart Vessels; 2013 Jul; 28(4):442-52. PubMed ID: 22618635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease?
    Miyazaki H; Babazono A; Nishi T; Maeda T; Imatoh T; Ichiba M; Une H
    BMC Pharmacol Toxicol; 2015 Sep; 16():22. PubMed ID: 26362195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study.
    Cid Ruzafa J; Paczkowski R; Boye KS; Di Tanna GL; Sheetz MJ; Donaldson R; Breyer MD; Neasham D; Voelker JR
    Int J Clin Pract; 2015 Aug; 69(8):871-82. PubMed ID: 26011029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study.
    Lindhardt M; Persson F; Zürbig P; Stalmach A; Mischak H; de Zeeuw D; Lambers Heerspink H; Klein R; Orchard T; Porta M; Fuller J; Bilous R; Chaturvedi N; Parving HH; Rossing P
    Nephrol Dial Transplant; 2017 Nov; 32(11):1866-1873. PubMed ID: 27507891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function.
    Moriyama T; Nakayama K; Ochi A; Amemiya N; Tsuruta Y; Kojima C; Itabashi M; Takei T; Uchida K; Nitta K
    Clin Exp Nephrol; 2012 Apr; 16(2):231-7. PubMed ID: 22038185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Diagnosis and Treatment of Diabetic Kidney Disease.
    Rodriguez F; Lee DJ; Gad SS; Santos MP; Beetel RJ; Vasey J; Bailey RA; Patel A; Blais J; Weir MR; Dash R
    Adv Ther; 2021 Aug; 38(8):4425-4441. PubMed ID: 34254257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study.
    Bjornstad P; Wiromrat P; Johnson RJ; Sippl R; Cherney DZI; Wong R; Rewers MJ; Snell-Bergeon JK
    Diabetes Care; 2019 Feb; 42(2):297-302. PubMed ID: 30482755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
    Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of renin angiotensin system inhibitors in patients with chronic kidney disease.
    Adam WR; Wright JR
    Intern Med J; 2016 May; 46(5):626-30. PubMed ID: 27170242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.